Jiménez-Yuste V - Search Results

1

Inhibitors in nonsevere haemophilia A: outcome and eradication strategies.

van Velzen AS, Eckhardt CL, Hart DP, Peters M, Rangarajan S, Mancuso ME, Smiers FJ, Khair K, Petrini P, Jiménez-Yuste V, Hay CR, van der Bom JG, Yee TT, Fijnvandraat K; INSIGHT study group. van Velzen AS, et al. Thromb Haemost. 2015 Jul;114(1):46-55. doi: 10.1160/TH14-11-0940. Epub 2015 Apr 16. Thromb Haemost. 2015. PMID: 25879247

2

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Collins P, Baudo F, Knoebl P, Lévesque H, Nemes L, Pellegrini F, Marco P, Tengborn L, Huth-Kühne A; EACH2 registry collaborators. Collins P, et al. Blood. 2012 Jul 5;120(1):47-55. doi: 10.1182/blood-2012-02-409185. Epub 2012 Apr 18. Blood. 2012. PMID: 22517903 Free PMC article.

3

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry.

Baudo F, Collins P, Huth-Kühne A, Lévesque H, Marco P, Nemes L, Pellegrini F, Tengborn L, Knoebl P; EACH2 registry contributors. Baudo F, et al. Blood. 2012 Jul 5;120(1):39-46. doi: 10.1182/blood-2012-02-408930. Epub 2012 May 22. Blood. 2012. PMID: 22618709 Free article.

4

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.

Eckhardt CL, van Velzen AS, Peters M, Astermark J, Brons PP, Castaman G, Cnossen MH, Dors N, Escuriola-Ettingshausen C, Hamulyak K, Hart DP, Hay CR, Haya S, van Heerde WL, Hermans C, Holmström M, Jimenez-Yuste V, Keenan RD, Klamroth R, Laros-van Gorkom BA, Leebeek FW, Liesner R, Mäkipernaa A, Male C, Mauser-Bunschoten E, Mazzucconi MG, McRae S, Meijer K, Mitchell M, Morfini M, Nijziel M, Oldenburg J, Peerlinck K, Petrini P, Platokouki H, Reitter-Pfoertner SE, Santagostino E, Schinco P, Smiers FJ, Siegmund B, Tagliaferri A, Yee TT, Kamphuisen PW, van der Bom JG, Fijnvandraat K; INSIGHT Study Group. Eckhardt CL, et al. Blood. 2013 Sep 12;122(11):1954-62. doi: 10.1182/blood-2013-02-483263. Epub 2013 Aug 7. Blood. 2013. PMID: 23926300 Free article.

5

Adult haemophilia A patients with inhibitors: successful immune tolerance induction with a single FVIII/VWF product.

Rangarajan S, Jiménez-Yuste V, Santagostino E. Rangarajan S, et al. Haemophilia. 2014 Nov;20(6):e414-7. doi: 10.1111/hae.12521. Epub 2014 Oct 21. Haemophilia. 2014. PMID: 25333452 No abstract available.

6

Prospective surveillance study of haemophilia A patients switching from moroctocog alfa or other factor VIII products to moroctocog alfa albumin-free cell culture (AF-CC) in usual care settings.

Parra Lopez R, Nemes L, Jimenez-Yuste V, Rusen L, Cid AR, Charnigo RJ, Baumann JA, Smith L, Korth-Bradley JM, Rendo P. Parra Lopez R, et al. Thromb Haemost. 2015 Oct;114(4):676-84. doi: 10.1160/TH14-09-0760. Epub 2015 Aug 13. Thromb Haemost. 2015. PMID: 26293201 Clinical Trial.

7

Clinical overview of Fanhdi/Alphanate (plasma-derived, VWF-containing FVIII concentrate) in immune tolerance induction in haemophilia A patients with inhibitors.

Jiménez-Yuste V, Oldenburg J, Rangarajan S, Kurth MH, Bozzo J, Santagostino E. Jiménez-Yuste V, et al. Haemophilia. 2016 Jan;22(1):e71-4. doi: 10.1111/hae.12857. Epub 2015 Nov 27. Haemophilia. 2016. PMID: 26612826 No abstract available.

8

Spanish Consensus Guidelines on prophylaxis with bypassing agents in patients with haemophilia and inhibitors.

López-Fernández MF, Altisent Roca C, Álvarez-Román MT, Canaro Hirnyk MI, Mingot-Castellano ME, Jiménez-Yuste V, Cid Haro AR, Pérez-Garrido R, Sedano Balbas C. López-Fernández MF, et al. Thromb Haemost. 2016 May 2;115(5):872-95. doi: 10.1160/TH15-07-0568. Epub 2016 Feb 4. Thromb Haemost. 2016. PMID: 26842562 Review.

9

Long-term outcome of haemophilia A patients after successful immune tolerance induction therapy using a single plasma-derived FVIII/VWF product: the long-term ITI study.

Jiménez-Yuste V, Oldenburg J, Rangarajan S, Peiró-Jordán R, Santagostino E. Jiménez-Yuste V, et al. Haemophilia. 2016 Nov;22(6):859-865. doi: 10.1111/hae.12986. Epub 2016 Jun 22. Haemophilia. 2016. PMID: 27329267

10

The evolving role and future relevance of plasma-derived therapies in the management of bleeding disorders.

Jiménez-Yuste V, Kruse-Jarres R, Rangarajan S, Altisent C. Jiménez-Yuste V, et al. Thromb Haemost. 2016 Aug 31;116 Suppl 1:S1. doi: 10.1160/TH16-01-0047. Epub 2016 Aug 16. Thromb Haemost. 2016. PMID: 27528277 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

274 results

Search Page